Clinicians only - cpms
CPMS
menu
Search
A11Y
Accessibility
Rare Diseases Working Groups
Hereditary Haemorrhagic Telangiectasia (HHT-WG)
Heritable Thoracic Aortic Diseases (HTAD-WG)
Medium Sized Arteries (MSA-WG)
Neurovascular Diseases (NEUROVASC-WG)
Pediatric and Primary Lymphedema (PPL-WG)
Vascular Anomalies (VASCA-WG)
Follow us
Contact us
Contact vascern
Goals and Expertise
Our missions
Funding
Goals for the future
Network
Experts
Working Groups
European Patient Advocacy Group (ePAG)
Coordination Project Team
Partnerships
Clinical Trials and Research
Clinical Trials/Observational Studies
Research Publications
Clinical Decision Support Tools
Clinical Practice Guidelines
Outcome Measures
Do’s and Don’ts
Expert consensus statements
Patient Pathways
Registry
Registry
Sub-registries
Training and Education
E-Learning
EU Trainings
Pills of Knowledge
Webinars
News & Events
News
Events & EU Calls
VASCERN Resources in all EU languages
All resources
IT Tools
ERN COLLABORATIVE PLATFORM (ECP)
CLINICAL PATIENT MANAGEMENT SYSTEM (CPMS)
VASCERN Mobile App
Search ...
Home
-
Working Groups
-
Neurovascular Diseases (NEUROVASC-WG)
-
Clinical Decision Support Tools
-
Clinical Outcome Measures
Neurovascular Diseases (NEUROVASC-WG)
Introduction
Diseases covered
RDWG’s Members
Members
Centers
Clinical Decision Support Tools
Patient Pathways
Do’s and Don’ts
Clinical Practice Guidelines (CPGs) adopted
Clinical Expert Consensus Statements Written
Clinical Outcome Measures
Registry
Research
Clinical Trials/Observational Studies
Research Publications
Training and Education
E-Learning
Pills of Knowledge (PoK)
Webinars
Clinical Outcome Measures
The Clinical Outcome Measures for the NEUROVASC WG is coming soon.
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset
